Gender differences in a clinical trial for prescription opioid dependence
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Although gender differences in substance use disorders have been identified, few studies have examined gender differences in prescription drug dependence. The aim of this study was to examine gender differences in clinical characteristics and treatment outcomes in a large clinical trial for prescription opioid dependence. Despite no pre-treatment differences in opioid dependence severity, women reported significantly greater functional impairment, greater psychiatric severity, and higher likelihood of using opioids to cope with negative affect and pain than men. Women were also more likely than men to have first obtained opioids via a legitimate prescription and to use opioids via the intended route of administration. Men reported significantly more alcohol problems than women. There were no significant gender differences in medication dose, treatment retention, or opioid outcomes. Thus, despite the presence of pre-treatment gender differences in this population, once the study treatment was initiated, women and men exhibited similar opioid use outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738 · cited 1×
“Self-report on the FTND is associated with nicotine intake (Heatherton et al., 1991; Courvoisier & Etter, 2010).”
BackgroundValidation of the Brief Pain Inventory for chronic nonmalignant pain
Tan, G., Jensen, M. P., Thornby, J. I., & Shanti, B. F. (2004) · The Journal of Pain · doi:10.1016/j.jpain.2003.12.005 · Cited by 1,416
Keller, S., Bann, C. M., Dodd, S. L., Schein, J., Mendoza, T. R., & Cleeland, C. S. (2004) · The Clinical Journal of Pain · doi:10.1097/00002508-200409000-00005 · Cited by 1,233
Substance abuse treatment entry, retention, and outcome in women: a review of the literature
Greenfield, S. F., Brooks, A. J., Gordon, S. M., Green, C. A., Kropp, F., McHugh, R. K., Lincoln, M., Hien, D., & Miele, G. M. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.05.012 · Cited by 1,055 · cited 2×
“A large literature exists on differences between men and women in terms of substancerelated problems (Greenfield et al., 2007), but it is not known whether these extend to prescription opioid users.”
BackgroundSelf-citationIncreasing deaths from opioid analgesics in the United States
Paulozzi, L. J., Budnitz, D. S., & Xi, Y. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1276 · Cited by 696 · cited 2×
“Consistent with these trends, mortality rates (Paulozzi et al., 2006), societal costs (Birnbaum et al.”
BackgroundSocietal costs of prescription opioid abuse, dependence, and misuse in the United States
Birnbaum, H. G., White, A. G., Schiller, M., Waldman, T., Cleveland, J. M., & Roland, C. L. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01075.x · Cited by 644
Weiss, R. D. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.121 · Cited by 540 · cited 10×
“Of note, as reported earlier (Weiss et al., 2011), there were no statistically significant gender X treatment interaction effects (ps ranged from .12-.83).”
BackgroundMethodInfluentialSelf-citationThe Addiction Severity Index at 25: Origins, contributions, and transitions
McLellan, A. T., Cacciola, J. C., Alterman, A. I., Rikoon, S. H., & Carise, C. (2006) · The American Journal on Addictions · doi:10.1080/10550490500528316 · Cited by 450
Telescoping and Gender Differences in Alcohol Dependence: New Evidence From Two National Surveys
Keyes, K. M., Martins, S. S., Blanco, C., & Hasin, D. S. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09081161 · Cited by 271
Gender and prescription opioids: Findings from the National Survey on Drug Use and Health
Back, S. E., Payne, R. L., Simpson, A. N., & Brady, K. T. (2010) · Addictive Behaviors · doi:10.1016/j.addbeh.2010.06.018 · Cited by 240
Validation of the Brief Pain Inventory in Patients Six Months After Cardiac Surgery
Gjeilo, K. H., Stenseth, R., Wahba, A., Lydersen, S., & Klepstad, P. (2007) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.01.010 · Cited by 100
Cited by
Sex and gender differences in substance use disorders
McHugh, R. K., Votaw, V. R., Sugarman, D. E., & Greenfield, S. F. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2017.10.012 · Cited by 1,076
Self-citationSchroeder, A. R., Dehghan, M., Newman, T. B., Bentley, J. P., & Park, K. T. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.5419 · Cited by 216
Let’s talk about sex: Differences in drug therapy in males and females
Madla, C. M., Gavins, F. K. H., Merchant, H. A., Orlu, M., Murdan, S., & Basit, A. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.014 · Cited by 167
Affective vulnerability in substance use disorders
McHugh, R. K., & Kneeland, E. T. (2019) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2019.01.011 · Cited by 80
Self-citationMusey, P. I., Linnstaedt, S. D., Platts-Mills, T. F., Miner, J. R., Bortsov, A. V., Safdar, B., Bijur, P., Rosenau, A., Tsze, D. S., Chang, A. K., et al. (2014) · Academic Emergency Medicine · doi:10.1111/acem.12529 · Cited by 55
“rehabilitation options.(26) More women are prescribed opioids in the ED, have higher dosages prescribed in the ED, and are more likely to have multiple and overlapping prescriptions that put them at risk for abuse.”
Metadata
- Authors
- McHugh, R. K., DeVito, E. E., Dodd, D., Carroll, K. M., Potter, J. S., Greenfield, S. F., Connery, H. S., & Weiss, R. D.
- Venue
- Journal of Substance Abuse Treatment
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 45
- Issue
- 1
- Pages
- 38-43
- ISSN
- 0740-5472 (ISSN-L)
- OpenAlex
- W2013448644
- Cited by
- 233
- References
- 12
- FWCI
- 7.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.